Roche's Elecsys IL-6 Test Receives FDA Emergency Use Authorization
June 04 2020 - 1:45AM
Dow Jones News
By Mauro Orru
Roche Holding AG said Thursday that the U.S. Food and Drug
Administration has issued an emergency use authorization for its
Elecsys IL-6 test, which helps identify severe inflammatory
response in patients with confirmed Covid-19.
The Swiss drugmaker said the decision makes the in vitro
diagnostic test accessible to patients in the United States and is
also available in markets accepting the CE mark.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
June 04, 2020 01:30 ET (05:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.